SFL is pleased to announce two upcoming training courses, each of which can be booked
separately, that will provide a comprehensive overview of the EU Medical Devices and
Combination Products regulations. These courses, which will be held in Basel, Switzer
land, are ideal for both experienced professionals and newcomers in medtech, pharma or related
life science industries. They aim to improve participant understanding of and compliance
with the current medical devices directives and anticipated changes.
On
Tuesday 23 April 2013, SFL will be running its course EU Medical Device Requirements
and Major Changes Ahead. This course will provide an in
-
depth overview of the EU medical
device regulatory framework. As well as learning how to comply with current requir
ements,
attendees will gain insight into forthcoming changes.
On Wednesday 24 April 2013, SFL will be running its related course Regulation of
Drug/Device Combination Products, Borderline Products and Companion Diagnostics
–
Status and Changes Ahead. Atten
dees will gain insight into how drug/device combination
products and companion diagnostics are regulated in the EU and the US. They will also learn
how to prepare for likely upcoming changes to EU device regulations impacting combination
products.
“Our tra
ining courses are designed to ensure that attendees fully understand the current
and upcoming changes in Medical Devices and Combination Products requirements and
how they can implement suitable compliance measures,” commented Shayesteh Fürst
-
Ladani. “Our
expertise in this dynamic field means that participants will gain knowledge that
they can put into practice in their company's daily operations.”
As part of its holistic approach, SFL also provides specialized training courses where
participants can benefi
t from the team’s cross
-
functional expertise and learn about the basis
and latest developments in Regulatory Affairs, Public Affairs, Legal Services and Medical
Communications.
SFL’s training courses have been approved by the SwAPP (Swiss Association of
Ph
armaceutical Professionals) Commission for Professional Development and SGPM (Swiss
Society of Pharmaceutical Medicine). All participants receive credits upon completion of the
SFL training course.